标题
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants
作者
关键词
-
出版物
CELL
Volume 186, Issue 2, Pages 279-286.e8
出版商
Elsevier BV
发表日期
2022-12-14
DOI
10.1016/j.cell.2022.12.018
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
- (2022) Delphine Planas et al. NATURE
- Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants
- (2022) Kang Wang et al. NATURE
- Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2
- (2022) Lihong Liu et al. NATURE
- Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicry
- (2022) Young-Jun Park et al. SCIENCE
- Potent cross-reactive antibodies following Omicron breakthrough in vaccinees
- (2022) Rungtiwa Nutalai et al. CELL
- 35B5 antibody potently neutralizes SARS-CoV-2 Omicron by disrupting the N-glycan switch via a conserved spike epitope
- (2022) Xiaofei Wang et al. Cell Host & Microbe
- Analysis of memory B cells identifies conserved neutralizing epitopes on the N-terminal domain of variant SARS-Cov-2 spike proteins
- (2022) Zijun Wang et al. IMMUNITY
- Antibody evasion properties of SARS-CoV-2 Omicron sublineages
- (2022) Sho Iketani et al. NATURE
- Molecular basis of receptor binding and antibody neutralization of Omicron
- (2022) Qin Hong et al. NATURE
- Long COVID after breakthrough SARS-CoV-2 infection
- (2022) Ziyad Al-Aly et al. NATURE MEDICINE
- BNT162b2 Protection against the Omicron Variant in Children and Adolescents
- (2022) Ashley M. Price et al. NEW ENGLAND JOURNAL OF MEDICINE
- An antibody class with a common CDRH3 motif broadly neutralizes sarbecoviruses
- (2022) Lihong Liu et al. Science Translational Medicine
- LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants
- (2022) Kathryn Westendorf et al. Cell Reports
- PARIS and SPARTA: Finding the Achilles’ Heel of SARS-CoV-2
- (2022) Viviana Simon et al. mSphere
- Association Between BNT162b2 Vaccination and Long COVID After Infections Not Requiring Hospitalization in Health Care Workers
- (2022) Elena Azzolini et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5
- (2022) Qian Wang et al. NATURE
- BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection
- (2022) Yunlong Cao et al. NATURE
- A broadly neutralizing antibody protects Syrian hamsters against SARS-CoV-2 Omicron challenge
- (2022) Biao Zhou et al. Nature Communications
- Patient-derived monoclonal antibody neutralizes SARS-CoV-2 Omicron variants and confers full protection in monkeys
- (2022) Craig Fenwick et al. Nature Microbiology
- An Antibody from Single Human V H -rearranging Mouse Neutralizes All SARS-CoV-2 Variants Through BA.5 by Inhibiting Membrane Fusion
- (2022) Sai Luo et al. Science Immunology
- Characterization of the enhanced infectivity and antibody evasion of Omicron BA.2.75
- (2022) Yunlong Cao et al. Cell Host & Microbe
- Antigenic characterization of the SARS-CoV-2 Omicron subvariant BA.2.75
- (2022) Qian Wang et al. Cell Host & Microbe
- Association of Primary and Booster Vaccination and Prior Infection With SARS-CoV-2 Infection and Severe COVID-19 Outcomes
- (2022) Dan-Yu Lin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- COVID ‘variant soup’ is making winter surges hard to predict
- (2022) Ewen Callaway NATURE
- Neutralization Escape by SARS-CoV-2 Omicron Subvariant BA.4.6
- (2022) Nicole P. Hachmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19-Associated Hospitalizations Among Vaccinated and Unvaccinated Adults 18 Years or Older in 13 US States, January 2021 to April 2022
- (2022) Fiona P. Havers et al. JAMA Internal Medicine
- Risk of Long COVID in People Infected With Severe Acute Respiratory Syndrome Coronavirus 2 After 2 Doses of a Coronavirus Disease 2019 Vaccine: Community-Based, Matched Cohort Study
- (2022) Daniel Ayoubkhani et al. Open Forum Infectious Diseases
- Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution
- (2022) Yunlong Cao et al. NATURE
- Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7
- (2021) Pengfei Wang et al. NATURE
- Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines
- (2021) Yunlong Cao et al. CELL RESEARCH
- Structures of SARS-CoV-2 B.1.351 neutralizing antibodies provide insights into cocktail design against concerning variants
- (2021) Shuo Du et al. CELL RESEARCH
- Assignment of Epidemiological Lineages in an Emerging Pandemic Using the Pangolin Tool
- (2021) Áine O’Toole et al. Virus Evolution
- Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity
- (2021) Mark W. Tenforde et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
- (2020) Dora Pinto et al. NATURE
- Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
- (2020) Lihong Liu et al. NATURE
- Potently neutralizing and protective human antibodies against SARS-CoV-2
- (2020) Seth J. Zost et al. NATURE
- Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2
- (2020) Kui K. Chan et al. SCIENCE
- SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
- (2020) Christopher O. Barnes et al. NATURE
- Inexpensive Multiplexed Library Preparation for Megabase-Sized Genomes
- (2015) Michael Baym et al. PLoS One
- Fast gapped-read alignment with Bowtie 2
- (2012) Ben Langmead et al. NATURE METHODS
- Integrative genomics viewer
- (2011) James T Robinson et al. NATURE BIOTECHNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now